1Spach MS. Mounting evidence that fibrosis generates a major mechanism for atrial fibrillation[ J ]. Circ Res, 2007, 101 (8) :743 -745.
2Healey JS, Morillo CA, Connolly SJ. Role of the renin-angiotensinaldosterone system in atrial fibrillation and cardiac remodeling [ J ]. Cur Opin Cardiol, 2005, 20( 1 ) :31 -37.
3Birnie DH, Gollob M, Healey JS. Clinical trials, the renin angiotensin system and atrial fibrillation [ J ]. Curr Opin Cardiol, 2006, 21 (4) :368 -375.
4Connell JM, Davies E. The new biology of aldosterone[ J]. J Endocrinol, 2005, 186 ( 1 ) : 1 - 20.
5Goette A, Haffmanns P, Enayati W, et al. Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation[ J]. Am J Cardiol, 2001, 88 (8) :906 -909.
6Kostin S, Klein G, Szalay Z, et al. Structural correlate of atrial fibrillation in human patients [ J ]. Cardiovasc Res, 2002, 54 (2) : 361 - 379.
7Everett TH 4th, Li H, Mangrum JM, et al. Electrical, morphological and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation [ J ]. Circulation, 2000, 102 (12) : 1454 - 1460.
8Verheule S, Sato T, Everett T 4th, et al. Increased vulnerability to atrial fibrillation in transgenic mice with selective alrial fibrosis caused by overexpression of TGF-betal [ J ], Circ Res, 2004, 94 (11) :1458 - 1465.
9Lombes M, Alfaidy N, Eugene E, et al. Prerequisite for aldosterone action: mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase in the human heart[J]. Circulation, 1995,92(2) :175 -182.
10Milliez P, Girerd X, Plouin PF, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism [J]. JAm Cnll Cardiol, 2005, 45(8) :1243 -1248.
